Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
Baxter
US Department of Justice
QuintilesIMS
Argus Health

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 8,883,499

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,883,499
Title:Systems and methods for isolating and using clinically safe adipose derived regenerative cells
Abstract: Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g., stem and/or progenitor cells, from adipose tissue. The systems and methods described herein provide rapid and reliable methods of separating and concentrating regenerative cells suitable for re-infusion into a subject.
Inventor(s): Hedrick; Marc H. (Encinitas, CA), Fraser; John K. (Los Angeles, CA), Schulzki; Michael J. (San Diego, CA), Byrnes; Bobby (San Diego, CA), Carlson; Grace (San Diego, CA), Schreiber; Ronda Elizabeth (San Diego, CA), Wulur; Isabella (West Hills, CA)
Assignee: Cytori Therapeutics, Inc. (San Diego, CA)
Application Number:13/452,349
Patent Claims:see list of patent claims

Details for Patent 8,883,499

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Sign Up Cytori Therapeutics, Inc. (San Diego, CA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,883,499

Country Patent Number Publication Date
South Africa 200507446 Apr 25, 2007
World Intellectual Property Organization (WIPO) 03053346 Aug 17, 2006
World Intellectual Property Organization (WIPO) 03053346 Jul 03, 2003
World Intellectual Property Organization (WIPO) 2004074457 May 18, 2006
World Intellectual Property Organization (WIPO) 2004074457 Sep 02, 2004
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Mallinckrodt
Covington
US Army
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.